Chapter 30. Primary Cutaneous T-Cell Lymphoma

  1. Hywel Williams MSC, PhD, FRCP Professor Dermato-Epidemiology Co-ordinating Editor
  1. Sean Whittaker MB, MD, FRCP Clinical Director for Dermatology HEAD1,2

Published Online: 14 JAN 2009

DOI: 10.1002/9781444300161.ch30

Evidence-Based Dermatology, Second Edition

Evidence-Based Dermatology, Second Edition

How to Cite

Whittaker, S. (2008) Primary Cutaneous T-Cell Lymphoma, in Evidence-Based Dermatology, Second Edition (ed H. Williams), Blackwell Publishing Ltd., Oxford, UK. doi: 10.1002/9781444300161.ch30

Editor Information

  1. Centre of Evidence-Based Dermatology, Nottingham University Hospital NHS Trust, Queen's Medical Centre, Nottingham, UK

Author Information

  1. 1

    Allergy and Sexual Health, St Johns Institute of Dermatology, Guy's and St Thomas Hospital, UK

  2. 2

    Skin Cancer Unit, Division of Genetics and Molecular Medicine, King's College London, UK

Publication History

  1. Published Online: 14 JAN 2009
  2. Published Print: 11 APR 2008

ISBN Information

Print ISBN: 9781405145183

Online ISBN: 9781444300161



  • primary cutaneous T-cell lymphomas (CTCLs);
  • Sézary syndrome;
  • topical mechlorethamine (nitrogen mustard) efficacy;
  • mechlorethamine effective topical therapy in mycosis fungoides;
  • phototherapy in mycosis fungoides/Sézary syndrome;
  • combination regimens and photochemotherapy;
  • extracorporeal photopheresis (ECP) in erythrodermic CTCL;
  • total skin electron beam therapy (TSEB);
  • myeloablative therapy and toxicity and systemic infections


This chapter contains sections titled:

  • Background

  • Questions

  • References